Panitumumab

Panitumumab

1

EMEA , the European Medicines Agency , has already restricted use of cetuximab and panitumumab to such patients .

欧洲药品局EMEA已经限制西妥昔单抗和帕尼单抗在这些患者使用。
2

For example , the Panel used data for the monoclonal antibodies cetuximab and panitumumab , which inhibit the EGF receptor ( EGFR ) in metastatic colorectal cancer .

例如，委员会使用的关于单克隆抗体西妥昔单抗和帕尼单抗（它们抑制转移性结直肠癌的表皮生长因子受体EGFR）的数据。